23Andme Holding Co. Grants New FDA Clearance to Report Additional BRCA Variants
23andMe Holding Co. announced the Company has received a U.S. Food and Drug Administration 510 clearance to expand its existing BRCA1/BRCA2 Genetic Health Risk Report. The clearance allows 23andMe...